Volume 16, Number 7—July 2010
Research
Zoonotic Transmission of Avian Influenza Virus (H5N1), Egypt, 2006–2009
Table 3
No. secondary complications | No. persons | Type of complications (no. persons), outcome | Case-fatality rate by no. complications (%) |
---|---|---|---|
1 | 6 | ARDS (n = 2), 2 died; bacteremia (n = 2), 2 alive; pneumonia (n = 1), 1 alive; shock (n = 1), 1 alive | 2/6 (33) |
2 | 11 | ARDS/pneumonia (n = 3), 2 died, 1 alive; ARDS/shock (n = 5), 1 died; ARDS/ renal failure (n = 1), 1 died; ARDS/coagulopathy (n = 1), 1 died; pneumonia/toxic myocarditis (n = 1), 1 alive | 9/11 (82) |
3 | 5 | ARDS/pneumonia/shock (n = 3), 3 died; ARDS/shock/renal failure (n = 1), 1 died; shock/renal failure/coagulopathy (n = 1), 1 died | 5/5 (100) |
4 | 2 | ARDS/pneumonia/shock/renal failure (n = 1), 1 died; ARDS/shock/renal failure/coagulopathy. (n = 1), 1 died | 2/2 (100) |
5 | 1 | ARDS/pneumonia/shock/ renal failure/coagulopathy (n = 1), 1 died | 1/1 (100) |
*ARDS, acute respiratory distress syndrome.
Page created: March 02, 2011
Page updated: March 02, 2011
Page reviewed: March 02, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.